๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Risk of fractures associated with treatment for benign prostate hyperplasia in men

โœ Scribed by P. Vestergaard; L. Rejnmark; L. Mosekilde


Publisher
Springer-Verlag
Year
2010
Tongue
English
Weight
138 KB
Volume
22
Category
Article
ISSN
0937-941X

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Urinary cholesterol excretion in men wit
โœ Dieter Juengst; Angelika Pickel; Erich Elsaesser; Franz J. Marx; Hans J. Karl ๐Ÿ“‚ Article ๐Ÿ“… 1979 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 406 KB ๐Ÿ‘ 2 views

Urinary excretion of nonesterified (NEC) and total cholesterol (TC) has been investigated in 79 patients with prostatic adenoma (BPH) and 48 patients with carcinoma of the prostate. Normal range of NEC was determined in 62 healthy individuals and was found to be 0.26-2.2 mg/24 hours (2 SD) with a me

Postvoid residual urine in the evaluatio
โœ J. L. H. Ruud Bosch ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› Springer-Verlag ๐ŸŒ English โš– 426 KB

Traditionally, the measurement of postvoid residual urinary volume (PVR) has played a prominent role in the evaluation of men with symptoms suggestive of benign prostatic hyperplasia (BPH). This article reviews current opinions about the cause of PVR, methods and accuracy of measurement, correlation

Two-dimensional electrophoresis of prost
โœ Jean-Philippe Charrier; Carole Tournel; Sandrine Michel; Pascal Dalbon; Michel J ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 156 KB ๐Ÿ‘ 2 views

Two-dimensional electrophoresis of prostatespecific antigen in sera of men with prostate cancer or benign prostate hyperplasia Prostate-specific antigen (PSA), the main marker for prostate cancer (PCa), is released from the prostate into the blood stream at nanogram level and may increase in PCa and

Effects of finasteride on health-related
โœ Girman, Cynthia J.; Kolman, Christopher; Liss, Charles L.; Bolognese, James A.; ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 702 KB

The effects of urinary symptoms on health-related quality of life (HRQL) are important in therapeutic decision making. Few have evaluated the treatment effects on HRQL in men with benign prostatic hyperplasia (BPH), even though increased urinary symptoms are associated with greater worry, bother, an